1. Home
  2. CWCO vs ESPR Comparison

CWCO vs ESPR Comparison

Compare CWCO & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CWCO
  • ESPR
  • Stock Information
  • Founded
  • CWCO 1973
  • ESPR 2008
  • Country
  • CWCO Cayman Islands
  • ESPR United States
  • Employees
  • CWCO N/A
  • ESPR N/A
  • Industry
  • CWCO Water Supply
  • ESPR Biotechnology: Pharmaceutical Preparations
  • Sector
  • CWCO Utilities
  • ESPR Health Care
  • Exchange
  • CWCO Nasdaq
  • ESPR Nasdaq
  • Market Cap
  • CWCO 554.4M
  • ESPR 660.1M
  • IPO Year
  • CWCO N/A
  • ESPR 2013
  • Fundamental
  • Price
  • CWCO $34.53
  • ESPR $3.68
  • Analyst Decision
  • CWCO Strong Buy
  • ESPR Buy
  • Analyst Count
  • CWCO 1
  • ESPR 7
  • Target Price
  • CWCO $40.00
  • ESPR $6.86
  • AVG Volume (30 Days)
  • CWCO 101.6K
  • ESPR 7.0M
  • Earning Date
  • CWCO 11-10-2025
  • ESPR 11-06-2025
  • Dividend Yield
  • CWCO 1.63%
  • ESPR N/A
  • EPS Growth
  • CWCO N/A
  • ESPR N/A
  • EPS
  • CWCO 1.05
  • ESPR N/A
  • Revenue
  • CWCO $130,832,698.00
  • ESPR $303,802,000.00
  • Revenue This Year
  • CWCO $1.99
  • ESPR $18.83
  • Revenue Next Year
  • CWCO $57.75
  • ESPR N/A
  • P/E Ratio
  • CWCO $32.74
  • ESPR N/A
  • Revenue Growth
  • CWCO N/A
  • ESPR 2.83
  • 52 Week Low
  • CWCO $22.69
  • ESPR $0.69
  • 52 Week High
  • CWCO $38.36
  • ESPR $3.94
  • Technical
  • Relative Strength Index (RSI)
  • CWCO 47.13
  • ESPR 71.27
  • Support Level
  • CWCO $32.96
  • ESPR $2.66
  • Resistance Level
  • CWCO $34.73
  • ESPR $3.26
  • Average True Range (ATR)
  • CWCO 1.23
  • ESPR 0.23
  • MACD
  • CWCO -0.17
  • ESPR 0.05
  • Stochastic Oscillator
  • CWCO 24.17
  • ESPR 94.43

About CWCO Consolidated Water Co. Ltd.

Consolidated Water Co Ltd is a water utility company. It develops and operates seawater desalination plants and water distribution systems. The company's business segments are; The retail segment operates the water utility for the Seven Mile Beach and West Bay areas of Grand Cayman Island, The bulk segment supplies potable water to government utilities in Grand Cayman and The Bahamas under long-term contracts, The services segment designs, constructs and sells water infrastructure and provides management and operating services to third parties. The manufacturing segment manufactures and services a wide range of custom and specialized water-related products applicable to commercial, municipal, and industrial water production, supply, and treatment, and the corporate segment.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: